Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michelle McSkane
Observed names:
M. McSkane,
McSkane, Michelle,
Michelle Mcskane
Institution:
Neurology, Inc
Observed institutions:
University of Southern California,
Loma Linda University Medical Center,
USC Norris Comprehensive Cancer Center,
Neurology, Inc
ORCID:
0000-0002-6849-9747
Observed ORCID:
0000-0002-6849-9747
OpenAlex ID:
A5039735618
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
2017
·
Ryuma Tokunaga
, Wu Zhang
, et al.
·
Cancer Treatment Reviews
·
1,773
PDF
Outlooks on Epstein-Barr virus associated gastric cancer
2018
·
Madiha Naseem
, Afsaneh Barzi
, et al.
·
Cancer Treatment Reviews
·
230
PDF
Colorectal cancer: epigenetic alterations and their clinical implications
2017
·
Alberto Puccini
, Martin D. Berger
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
85
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives
2018
·
Francesca Battaglin
, Alberto Puccini
, et al.
·
Journal of Cancer Metastasis and Treatment
·
9
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study
2018
·
Michelle McSkane
, Sebastian Stintzing
, et al.
·
Clinical Colorectal Cancer
·
7
The Impact of Non-opioid Analgesic Usage on Total Opioid Load During Traumatic Brain Injury Rehabilitation: A Retrospective Study
2023
·
Joshua D King
, Kylo Cautivar
, et al.
·
Cureus
·
5
PDF
Circadian clock gene PER1 mutations in colorectal cancer (CRC).
2018
·
Francesca Battaglin
, Joanne Xiu
, et al.
·
Journal of Clinical Oncology
·
2
Polymorphism in the circadian clock pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials.
2018
·
Francesca Battaglin
, Shu Cao
, et al.
·
Journal of Clinical Oncology
·
2
Polymorphisms in beta-defensin pathways and clinical outcomes in metastatic colorectal cancer patients treated with FOLFIRI-bevacizumab in two randomized phase III trials.
2018
·
Madiha Naseem
, Martin D Berger
, et al.
·
Journal of Clinical Oncology
·
2
Genetic variations within the HER3 gene predict outcome for mCRC patients treated with first-line FOLFIRI/bevacizumab or FOLFIRI/cetuximab: Data from FIRE-3
2018
·
M.D. Berger
, S. Stintzing
, et al.
·
Annals of Oncology
·
1
Polymorphism in cancer-associated fibroblasts (CAFs) related genes and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) enrolled in two independent randomized phase III trials: TRIBE and FIRE-3.
2018
·
Alberto Puccini
, Martin D. Berger
, et al.
·
Journal of Clinical Oncology
·
1
Resident Driven Lumbar Puncture Protocol Implementation to Improve Clinical Practice Across Disciplines (P1-14.007)
2026
·
Michelle McSkane
, Kevin Counterman
, et al.
·
Neurology
Abstract 2614: Macrophage erythroblast attacher (MAEA) polymorphisms are associated with clinical outcome in TRIBE study mCRC patients treated with 5-fluorouracil/bevacizumab-based therapy
2018
·
Shivani Soni
, Yuji Miyamoto
, et al.
·
Cancer Research
Genetic variations in the β2M/HLA-E immunomodulatory complex to predict outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line FOLFIRI/Cetuximab: Data from the phase III FIRE-3 trial.
2018
·
Madiha Naseem
, Sebastian Stintzing
, et al.
·
Journal of Clinical Oncology
Genetic variants within the glucocorticoids related genes to predict outcome in patients with metastatic colorectal cancer (mCRC).
2018
·
Alberto Puccini
, Fotios Loupakis
, et al.
·
Journal of Clinical Oncology
The impact of Th17 cell pathway-related genetic variants in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy.
2018
·
Ryuma Tokunaga
, Shu Cao
, et al.
·
Journal of Clinical Oncology
Molecular characterization of appendiceal cancer and comparison with right-sided (R-CRC) and left-sided colorectal cancer (L-CRC).
2018
·
Ryuma Tokunaga
, Joanne Xiu
, et al.
·
Journal of Clinical Oncology
The impact of Tfh cell/ B cell pathway-related genetic variants in metastatic colorectal cancer patients with bevacizumab-based chemotherapy.
2018
·
Ryuma Tokunaga
, Shu Cao
, et al.
·
Journal of Clinical Oncology
Genetic variants in methylation and demethylation pathways to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI/Bev: Data from TRIBE and FIRE-3 trials.
2018
·
Alberto Puccini
, Fotios Loupakis
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
22
Citation count:
2,117
H-index:
5
I10-index:
3
Year
Topic
Type